Challenges in the diagnosis and treatment of secondary acute myeloid leukemia

Gert Ossenkoppele1, Pau Montesinos2

  • 1VU University Medical Center, 2PK Brug 016, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands.

Insights

Secondary AML (sAML), a challenging leukemia subtype, historically shows poor outcomes. Novel therapies like CPX-351 offer improved front-line treatment options for older adults with high-risk sAML.

Area of Science:

  • Hematology
  • Oncology
  • Pharmacology

Background:

  • Secondary acute myeloid leukemia (sAML), including therapy-related AML (tAML) and AML with myelodysplasia-related changes (AML-MRC), represents a significant portion of AML cases (10%-30%).
  • sAML is characterized by a poor prognosis, particularly in older adults, with historically suboptimal outcomes using conventional chemotherapy regimens.
  • Current treatment strategies for sAML include intensive chemotherapy (e.g., 7+3) or less aggressive options for elderly or unfit patients, but efficacy remains limited.

Purpose of the Study:

  • To review the current understanding of secondary AML (sAML) diagnosis and treatment strategies.
  • To highlight the efficacy of novel therapeutic approaches, specifically CPX-351, in improving outcomes for patients with high-risk sAML.
  • To emphasize the need for optimized diagnostic and therapeutic paradigms for sAML to enhance patient survival and quality of life.

Main Methods:

  • Literature review of secondary AML (sAML) classification, treatment history, and emerging therapies.
  • Analysis of clinical trial data and treatment guidelines pertaining to sAML management.
  • Focus on the role of CPX-351, a liposomal formulation of cytarabine and daunorubicin, in the context of sAML treatment.

Main Results:

  • CPX-351 has demonstrated improved front-line outcomes in older patients diagnosed with high-risk sAML.
  • CPX-351 is approved for adults with newly diagnosed therapy-related AML (tAML) or AML with myelodysplasia-related changes (AML-MRC).
  • The National Comprehensive Cancer Network (NCCN) guidelines recommend CPX-351 as a Category 1 option for induction therapy in patients over 60 with high-risk sAML.

Conclusions:

  • CPX-351 represents a significant advancement in the front-line treatment of older adults with high-risk secondary AML.
  • While CPX-351 shows promise, further research into optimal diagnostic criteria and novel therapies for specific sAML subgroups is warranted.
  • Improving the management of sAML requires a comprehensive approach, integrating diagnostic clarity with effective therapeutic strategies to enhance outcomes in this vulnerable patient population.

Related Concept Videos

Secondary Active Transport01:55

Secondary Active Transport

One example of how cells use the energy contained in electrochemical gradients is demonstrated by glucose transport into cells. The ion vital to this process is sodium (Na+), which is typically present in higher concentrations extracellularly than in the cytosol. Such a concentration difference is due, in part, to the action of an enzyme “pump” embedded in the cellular membrane that actively expels Na+ from a cell. Importantly, as this pump contributes to the high concentration of...
137.4K
Secondary Active Transport01:32

Secondary Active Transport

One example of how cells use the energy contained in electrochemical gradients is demonstrated by glucose transport into cells. The ion vital to this process is sodium (Na+), which is typically present in higher concentrations extracellularly than in the cytosol. Such a concentration difference is due, in part, to the action of an enzyme "pump" embedded in the cellular membrane that actively expels Na+ from a cell. Importantly, as this pump contributes to the high concentration of...
9.4K
Secondary Healthcare System01:11

Secondary Healthcare System

Secondary healthcare is offered by a specialist, generally in hospitals or clinics for patients referred by primary healthcare providers. It occurs when a person has an illness or injury that requires specific medical care. Secondary care is often referred to as acute care. Secondary care can range from uncomplicated care to repair a minor laceration or treat a strep throat infection to more complicated emergent care, such as treating a head injury sustained in an automobile accident. Whatever...
2.0K
Primary and Secondary Growth in Roots and Shoots03:02

Primary and Secondary Growth in Roots and Shoots

Vascular plants, which account for over 90% of the Earth’s vegetation, all undergo primary growth—which lengthens roots and shoots. Many land plants, notably woody plants, also undergo secondary growth—which thickens roots and shoots.
60.3K
Secondary Distribution01:25

Secondary Distribution

Secondary distribution systems provide electrical energy at the utilization voltage levels from distribution transformers to customer meters. Typical secondary voltages in the United States include 120/240 V for residential use, 208Y/120 V for residential and commercial use, and 480Y/277 V for industrial and high-rise commercial use.
In residential areas, 120/240 V single-phase, three-wire service is commonly used for lighting, outlets, and large appliances. Urban areas with high-density loads...
564
Secondary Lymphoid Organs01:15

Secondary Lymphoid Organs

Secondary organs, including lymph nodes, the spleen, and mucosa-associated lymphoid tissue (MALT), work harmoniously to protect us from disease and infection.
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...
9.0K